T-cell proliferation/Treg-suppression assay

DA Dennis O. Adeegbe
SL Shengwu Liu
MH Maureen M. Hattersley
MB Michaela Bowden
CZ Chensheng W. Zhou
SL Shuai Li
RV Raven Vlahos
MG Michael Grondine
ID Igor Dolgalev
EI Elena V. Ivanova
MQ Max M. Quinn
PG Peng Gao
PH Peter S. Hammerman
JB James E. Bradner
JD J. Alan Diehl
AR Anil K. Rustgi
AB Adam J. Bass
AT Aristotelis Tsirigos
GF Gordon J. Freeman
HC Huawei Chen
KW Kwok-Kin Wong
request Request a Protocol
ask Ask a question
Favorite

For mouse Treg-suppression assays, CD4+CD25hi Tregs in tumor cell suspensions were sorted into KLRG1+ or KLRG1- cells and cultured at 1:2, 1:4, and 1:8 ratios with Carboxyfluorescein diacetate succinimidyl ester (CFSE)-labelled CD4+CD25- cells (0.25×105) isolated from the spleen of the same mouse. T cell–depleted, mitomycin C–treated splenocytes (0.25×105) were added as antigen presenting cells (APCs) and cultures were stimulated with soluble anti-CD3 (clone 2C11, ebioscience) at 0.5 µg/ml concentration for 3 days.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A